Heron Therapeutics Statistics

Total Valuation

HRTX has a market cap or net worth of $269.97 million. The enterprise value is $381.33 million.

Market Cap	269.97M
Enterprise Value	381.33M

Important Dates

The next confirmed earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

HRTX has 151.67 million shares outstanding. The number of shares has increased by 31.37% in one year.

Shares Outstanding	151.67M
Shares Change (YoY)	+31.37%
Shares Change (QoQ)	+0.73%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	63.60%
Float	115.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.01
Forward PS	3.39
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.38

Current Ratio	2.38
Quick Ratio	1.76
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.17

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-8.58%
Return on Capital (ROIC)	-13.97%
Revenue Per Employee	$1.08M
Profits Per Employee	-$381,960
Employee Count	126
Asset Turnover	0.65
Inventory Turnover	2.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +179.48% in the last 52 weeks. The beta is 1.81, so HRTX's price volatility has been higher than the market average.

Beta (5Y)	1.81
52-Week Price Change	+179.48%
50-Day Moving Average	1.89
200-Day Moving Average	2.60
Relative Strength Index (RSI)	44.45
Average Volume (20 Days)	1,369,692

Short Selling Information

The latest short interest is 30.64 million, so 20.20% of the outstanding shares have been sold short.

Short Interest	30.64M
Short Previous Month	31.70M
Short % of Shares Out	20.20%
Short % of Float	26.46%
Short Ratio (days to cover)	15.54

Income Statement

In the last 12 months, HRTX had revenue of $136.36 million and -$48.13 million in losses. Loss per share was -$0.31.

Revenue	136.36M
Gross Profit	40.59M
Operating Income	-28.79M
Pretax Income	-48.13M
Net Income	-48.13M
EBITDA	-26.02M
EBIT	-28.79M
Loss Per Share	-$0.31

Full Income Statement

Balance Sheet

The company has $67.35 million in cash and $178.71 million in debt, giving a net cash position of -$111.37 million or -$0.73 per share.

Cash & Cash Equivalents	67.35M
Total Debt	178.71M
Net Cash	-111.37M
Net Cash Per Share	-$0.73
Equity (Book Value)	-37.94M
Book Value Per Share	-0.25
Working Capital	110.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$20.84 million and capital expenditures -$1.68 million, giving a free cash flow of -$22.52 million.

Operating Cash Flow	-20.84M
Capital Expenditures	-1.68M
Free Cash Flow	-22.52M
FCF Per Share	-$0.15

Full Cash Flow Statement

Margins

Gross margin is 29.76%, with operating and profit margins of -21.11% and -35.29%.

Gross Margin	29.76%
Operating Margin	-21.11%
Pretax Margin	-35.29%
Profit Margin	-35.29%
EBITDA Margin	-19.08%
EBIT Margin	-21.11%
FCF Margin	-16.51%

Dividends & Yields

HRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.37%
Shareholder Yield	-31.37%
Earnings Yield	-17.83%
FCF Yield	-8.34%

Analyst Forecast

The average price target for HRTX is $6.00, which is 237.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	237.08%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	18.78%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 13, 2014. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jan 13, 2014
Split Type	Reverse
Split Ratio	0.05:1

Scores

HRTX has an Altman Z-Score of -10.81 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.81
Piotroski F-Score	4